Evotec and Variant Bio Partner to Discover and Develop Fibrosis Treatments
The Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read moreThe Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read moreFrench biotech Medincell announced on Tuesday entering into a collaboration with AbbVie, to co-develop up to six innovative long-acting injectable
Read morePreclinical data shows that Nutcracker’s mRNA drug candidate NTX-470 effectively targets CD3 T cells, demonstrating selective engagement with minimal unintended
Read moreCacoReady, a Useful Cell Model to Predict Drug-Induced Gastrointestinal Toxicity A ReadyCell .pdf Case Study – Author: Marta Olle Monge,
Read moreChoosing the most appropriate well system format, whether it’s a transwell, non-transwell, or individual transwell, can drastically affect the outcome
Read moreThe use of Fluorescence Cross-Correlation Spectroscopy (FCCS) in Drug Discovery and Development An Intana Bioscience .pdf Case Study/Presentation The .pdf
Read moreThe unique rapid plasma protein binding assay for sticky and tightly bound compounds can be used with plasma from any
Read moreIn vitro mammalian cells such as Caco-2 or MDCKII, crucial for preclinical research and drug discovery, are highly challenging to
Read moreReadyCell has developed an advanced range of ready-to-use HEK293 Cell-based In Vitro Plates for studying uptake drug-transporter interactions in preclinical
Read moreCutting-edge CacoReady Cell-based Plates with pre-developed Caco-2 cells for in vitro permeability assessment have been a key tool in a
Read more